Market Currents
Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for...
-
Thursday, January 5, 2012, 9:28 AM ETBaxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for hemophilia A. The firm says the phase I trial is the first step in assessing if the drug can be infused less frequently.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
